AU6643596A - Isolation of amplified genes via cdna subtractive hybridization - Google Patents

Isolation of amplified genes via cdna subtractive hybridization

Info

Publication number
AU6643596A
AU6643596A AU66435/96A AU6643596A AU6643596A AU 6643596 A AU6643596 A AU 6643596A AU 66435/96 A AU66435/96 A AU 66435/96A AU 6643596 A AU6643596 A AU 6643596A AU 6643596 A AU6643596 A AU 6643596A
Authority
AU
Australia
Prior art keywords
isolation
subtractive hybridization
amplified genes
genes via
via cdna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU66435/96A
Inventor
Bertrand C. Liang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
US Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, US Government filed Critical US Department of Health and Human Services
Publication of AU6643596A publication Critical patent/AU6643596A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU66435/96A 1995-08-11 1996-08-08 Isolation of amplified genes via cdna subtractive hybridization Abandoned AU6643596A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US218895P 1995-08-11 1995-08-11
US002188 1995-08-11
PCT/US1996/012542 WO1997007244A1 (en) 1995-08-11 1996-08-08 ISOLATION OF AMPLIFIED GENES VIA cDNA SUBTRACTIVE HYBRIDIZATION

Publications (1)

Publication Number Publication Date
AU6643596A true AU6643596A (en) 1997-03-12

Family

ID=21699602

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66435/96A Abandoned AU6643596A (en) 1995-08-11 1996-08-08 Isolation of amplified genes via cdna subtractive hybridization

Country Status (2)

Country Link
AU (1) AU6643596A (en)
WO (1) WO1997007244A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE438719T1 (en) * 1997-03-07 2009-08-15 Siemens Healthcare Diagnostics SPECIFIC MARKER FOR PROSTATE CANCER
US6399334B1 (en) 1997-09-24 2002-06-04 Invitrogen Corporation Normalized nucleic acid libraries and methods of production thereof
US6482597B1 (en) 1999-12-17 2002-11-19 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US7579160B2 (en) 1998-03-18 2009-08-25 Corixa Corporation Methods for the detection of cervical cancer
US6531315B1 (en) 1998-03-18 2003-03-11 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6312695B1 (en) 1998-03-18 2001-11-06 Corixa Corporation Compounds and methods for therapy of lung cancer
US6821518B1 (en) 1998-03-18 2004-11-23 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US7049063B2 (en) 1998-03-18 2006-05-23 Corixa Corporation Methods for diagnosis of lung cancer
US7258860B2 (en) 1998-03-18 2007-08-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6518256B1 (en) 1998-03-18 2003-02-11 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6660838B1 (en) 1998-03-18 2003-12-09 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6696247B2 (en) 1998-03-18 2004-02-24 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6960570B2 (en) 1998-03-18 2005-11-01 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6706262B1 (en) 1998-03-18 2004-03-16 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6426072B1 (en) 2000-08-02 2002-07-30 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6737514B1 (en) 1998-12-22 2004-05-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6413720B1 (en) 1999-01-11 2002-07-02 Signal Pharmaceuticals, Inc. Method for the affinity isolation of newly synthesized RNA
EP1169347B1 (en) * 1999-04-02 2008-07-02 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
WO2001009387A1 (en) * 1999-07-29 2001-02-08 Northeastern University Isolation of novel hemapoietic genes by representational difference analysis
CA2692552C (en) 2001-03-12 2013-01-22 Japan Tobacco Inc. Novel protein isolated from pleurotus cornucopiae

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107023A (en) * 1988-06-17 2000-08-22 Genelabs Technologies, Inc. DNA amplification and subtraction techniques
US5362623A (en) * 1991-06-14 1994-11-08 The John Hopkins University Sequence specific DNA binding by p53
JP3164814B2 (en) * 1990-08-27 2001-05-14 科学技術振興事業団 Preparation of homogenized cDNA library
JP3315439B2 (en) * 1992-07-21 2002-08-19 住友電気工業株式会社 Cell specific cDNA isolation method and library preparation method
US5436142A (en) * 1992-11-12 1995-07-25 Cold Spring Harbor Laboratory Methods for producing probes capable of distingushing variant genomic sequences

Also Published As

Publication number Publication date
WO1997007244A1 (en) 1997-02-27

Similar Documents

Publication Publication Date Title
AU6643596A (en) Isolation of amplified genes via cdna subtractive hybridization
AU3116497A (en) Subtractive amplification
AU3809795A (en) Genetic control of flowering
AU6042396A (en) Amplification of nucleic acid sequences
AU2804597A (en) Synthesis of fluorophore-labeled dna
AU5887296A (en) Process for the transcriptionless amplification of nucleic aids
AU6037199A (en) Rac-like genes from maize and methods of use
AU2657095A (en) Synthesis of oligonucleotides
AU6614696A (en) Inhibition of gene expression
AU4787697A (en) Therapeutic gene
EP0724116A3 (en) Ceramic lining
AU9128798A (en) Genotyping of human cyp3a4
AU6614596A (en) Inhibition of gene expression
AU1024397A (en) Disruption of expression of multiple alleles of mammalian genes
AU1841395A (en) Temperature regulated hybridization chamber
AU4940296A (en) Genetic modification of plants
AU3362293A (en) Control of gene transcription
AU4173497A (en) Monocot seed gene expression system
AU2548095A (en) Human inhibitor of apoptosis gene 1
AU1820995A (en) Biopolymers derived from hydrolyzable diacid fats
AU1576297A (en) Synthesis of h-phase products
AU5989396A (en) Origin of replication complex genes
AU2571892A (en) Subtractive hybridization cloning for probes for gene isolation and mapping
AUPN107095A0 (en) Manipulation of gene expression
AU5877196A (en) Gene and protein for modification of the gravitropic respons e